Current share price for DRUG : $7.860 0.08 (1.01%)+
Betashares Global Healthcare ETF - Currency Hedged (DRUG) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Betashares Global Healthcare ETF -Currency Hedged (DRUG) provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector. The Fund aims to track the performance of an index (before fees and expenses) which provides exposure to the performance of the largest global healthcare companies by market capitalization (excluding companies in Australia), hedged into Australian dollars.
ASX Code | DRUG |
Website | http://www.betashares.com.au |
Industry/Sector | Asset Management & Custody Banks |
Market Cap ($M) | 160 |
DRUG Share Price | $7.860 |
Day High | $7.900 |
Day Low | $7.840 |
Last Close | $7.940 |
DRUG Share Price Movement | $0.08 ( 1.01% ) |
Equity World Other | |
MSCI World Ex Australia NR AUD | |
![]() ![]() ![]() |
|
Not Rated | |
Investment Fund | |
4 Aug 2016 | |
$155.72 million (as at 10 Sep 2025) |
1 Month % | 3 Month % | 6 Month % | 1 Year % p.a. | 2 Year % p.a. | 3 Year % p.a. | 5 Year % p.a. | 10 Year % p.a. | |
---|---|---|---|---|---|---|---|---|
Total return | -2.06 | -5.59 | -10.72 | -14.31 | -1.09 | 0.03 | 4.28 | - |
Growth return | 4.9 | 3.19 | -7.93 | -14.36 | -0.44 | 2.43 | 3.06 | - |
Income return (Yield) | -6.96 | -8.78 | -2.79 | 0.05 | -0.65 | -2.4 | 1.22 | - |
Market index (MSCI World Ex Australia NR AUD) |
||||||||
Total return | 0.92 | 6.62 | 5.1 | 20.06 | 19.45 | 20.5 | 15.74 | 12.6 |
Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
---|---|---|---|---|---|---|---|
HFResult | 0¢ | 0% | 1 Jul 2025 | 16 Jul 2025 | - | - | - |
Result | 2.73¢ | 0% | 2 Jan 2025 | 17 Jan 2025 | - | - | - |
HFResult | 22.3¢ | 0% | 1 Jul 2024 | 16 Jul 2024 | - | - | - |
See all dividends from Betashares Global Healthcare ETF - Currency Hedged (DRUG) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
---|---|---|---|---|---|---|---|
2024A | $18.93 | $93.30 | 169.40% | 8.70 | 25.00 | 3.10% | 0.0% |
2023A | $6.99 | $34.60 | 366.60% | 22.10 | 2.60 | 0.30% | 0.0% |
2022A | $1.57 | $7.40 | -92.80% | 103.70 | 1.90 | 0.30% | 0.0% |
Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
2022 A | 2023 A | 2024 A | 2022 A | 2023 A | 2024 A | 2022 A | 2023 A | 2024 A | ||
Betashares Global Healthcare ETF - Currency Hedged (DRUG) | $160M | 1.6941 | 0.0000 | 0.0000 | 8.3843 | 0.0000 | 0.0000 | 3.19% | 0.00% | 0.00% |
Insignia Financial Ltd (IFL) | $3,025M | -0.1898 | -0.0413 | 0.0296 | 11.7234 | 12.2289 | 11.8778 | 0.00% | 0.00% | 0.00% |
Netwealth Group Limited (NWL) | $7,795M | 0.3930 | 0.1343 | 0.1791 | 66.9263 | 59.0015 | 50.0394 | 1.21% | 1.34% | 1.61% |
Pinnacle Investment Management Group Limited (PNI) | $4,224M | 0.3714 | 0.1854 | 0.1853 | 29.8558 | 25.1859 | 21.2477 | 3.22% | 3.55% | 4.09% |
Perpetual Limited (PPT) | $2,241M | 0.1876 | 0.0612 | -0.0498 | 11.5834 | 10.9156 | 11.4874 | 5.89% | 6.65% | 6.65% |
Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
---|---|---|---|---|
Company | 0.00 | 8.51 | 0.93 | 0.00 |
Market | 0.27 | 15.30 | 1.18 | 0.89 |
Sector | 0.00 | 0.00 | 0.00 | 0.00 |
Name | Position | Start Date |
---|---|---|
Mr Alex Vynokur | Executive Director | 21 Sep 2009 |
Mr Jason Gellert | Executive Director | 5 Mar 2021 |
Mr Edward Sippel | Non-Executive Director | 5 Mar 2021 |
Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
---|
See all changes in directors' interest & trades for Betashares Global Healthcare ETF - Currency Hedged (DRUG) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
Betashares Global Healthcare ETF - Currency Hedged's (DRUG) current share price is $7.86. This constitutes a price movement of 0.25% when compared to the share price 7 days ago and is -13.15% below DRUG's 12-month high of $9.05 per share. Prices are delayed by at least 20 minutes.
Relative to the previous close share price of $7.94, Betashares Global Healthcare ETF - Currency Hedged's (DRUG) current share price of $7.86 constitutes a movement of -$0.08 or -1.01%. Betashares Global Healthcare ETF - Currency Hedged's (DRUG) share price movement is -0.25% when compared to 7 days ago and is -13.15% below DRUG's 52-week high of $9.05.
Betashares Global Healthcare ETF - Currency Hedged's (DRUG) 52-week high is $9.05 which was reached on 17 Sep 2024. Relative to this, DRUG's current share price of $7.86 constitutes a -$1.19 or -13.15% drop since that high of $9.05 per DRUG share.
Betashares Global Healthcare ETF - Currency Hedged's (DRUG) 52-week low is $7.27 which was reached on 15 May 2025. Relative to this, DRUG's current share price of $7.86 constitutes a $0.59 or 8.12% gain since that low of $7.27 per DRUG share.
Upcoming ex-distribution date: 1 Jul 2025
Upcoming record date: 2 Jul 2025
Upcoming payment date: 16 Jul 2025
ETFs, such as Betashares Global Healthcare ETF - Currency Hedged (DRUG), pay distributions instead of dividends. The difference is that dividends are declared by companies from part of the profits made during any given year and the company’s management decide the amount of earnings retained verses how much to pay out to investors. An ETF, like Betashares Global Healthcare ETF - Currency Hedged (DRUG), must pay out all realised income. This is a combination of any dividends received plus capital gains realised from the buying and selling of underlying holdings within Betashares Global Healthcare ETF - Currency Hedged (DRUG).
A distribution has three key dates:
Ex-distribution date: Date the distribution value leaves the ETF. This will normally correspond with the ETF unit price dropping in value by the same amount as the distribution.
Record date: Date someone must be on the unit registry to receive the distribution.
Payment date date: Date the distribution is paid to the unit holder.
Betashares Global Healthcare ETF - Currency Hedged (DRUG) has a current dividend yield of n/a this year. Last year's dividend yield was 2.80%. The dividend yield for DRUG is a ratio that tells you the percentage of Betashares Global Healthcare ETF - Currency Hedged (DRUG)'s share price that it pays out in dividends each year. The dividend yield is calculated by dividing the annual dividends by the current share price.
The "management expense ratio" (MER) for Betashares Global Healthcare ETF - Currency Hedged (DRUG) is 0.57%. This is the total expense for operating an ETF or managed fund like Betashares Global Healthcare ETF - Currency Hedged (DRUG). This includes management fees and other operating expenses which all come out of an investor's return.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.